Physician profile
Brian E Lieb
NPI 1871598268
$1,945.81
in general payments reported to CMS, 2019-2025
19 companies · $446 in 2025
The $446 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.44 · 2020: $55.94 · 2021: $119 · 2022: $333 · 2023: $303 · 2024: $636 · 2025: $446.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,385.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,384.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $251.70 | 2023-2025 | Jardiance |
| Astrazeneca Pharmaceuticals Lp | $247.48 | 2019-2025 | Farxiga, Airsupra |
| Abbott Laboratories | $192.71 | 2023-2025 | Freestyle Libre 3 |
| Novo Nordisk INC | $186.87 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $182.37 | 2019-2024 | Xarelto |
| Exact Sciences Corporation | $177.48 | 2024-2025 | Cologuard Collection Kit |
| Pfizer INC. | $137.37 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $122.06 | 2022-2024 | Eliquis |
| Merck Sharp & Dohme LLC | $106.65 | 2019-2024 | Vaxneuvance, Vaxelis, Gardasil |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $95.37 | 2024-2025 | Xifaxan, Trulance |
| Genentech USA, INC. | $65.79 | 2020-2021 | |
| Dexcom, INC. | $30.68 | 2021-2023 | Dexcom G6 Transmitter |
| Inspire Medical Systems, INC. | $29.71 | 2024 | Inspire |
| Lilly USA, LLC | $28.78 | 2022 | |
| Boston Scientific Corporation | $25.25 | 2025 | Watchman Flx |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $22.47 | 2025 | Rexulti |
| Abbvie INC. | $17.11 | 2024 | |
| Novartis Pharmaceuticals Corporation | $14.71 | 2019 | |
| Glaxosmithkline, LLC. | $11.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Lieb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.